Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
400.4 USD | +1.13% | +6.31% | +30.49% |
Apr. 24 | Baird Adjusts Medpace Price Target to $454 From $446, Maintains Outperform Rating | MT |
Apr. 23 | Transcript : Medpace Holdings, Inc., Q1 2024 Earnings Call, Apr 23, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.49% | 12.24B | |
+1.78% | 42.75B | |
+47.70% | 41.61B | |
+12.16% | 41.34B | |
-8.83% | 26.59B | |
+7.50% | 25.49B | |
-23.09% | 18.12B | |
-1.95% | 11.76B | |
+8.32% | 11B | |
-16.33% | 10.07B |
- Stock Market
- Equities
- MEDP Stock
- News Medpace Holdings, Inc.
- UBS Adjusts Medpace Price Target to $480 From $452, Maintains Buy Rating